Clinical Trial Update: Study to ONO-4538 in Patients With Rhabdoid Tumor [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ONO-4538 (nivolumab) in rhabdoid tumor patients is ongoing and currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhabdoid Tumor

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Ono Pharmaceutical Co., Ltd. | Conditions: Rhabdoid Tumor | Phase 2 | Status: RECRUITING